Albertsons Q1: identical sales +4.9%; adj. EPS $0.93 vs $1.00 YoY

Albertsons Companies, Inc.

2023-Q1 EPS reported $0.72 revenue$24,050,200,000

Net sales $24.1B (+3.4% YoY); identical sales +4.9% driven by inflation, pharmacy, digital.
Net income $417M ($0.72 EPS); adjusted net income $546M ($0.93 EPS), down from $582M.
Adjusted EBITDA $1,319M (5.5% margin) vs $1,420M (6.1%); decline due to fewer COVID vaccines.
Digital sales +22%; loyalty members +16% to 35.9M; capital expenditures $623M for 43 remodels.
Expects ~$130M headwind to adj. EBITDA from COVID vaccine/test kit decline in remaining quarters.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Albertsons Companies, Inc. reported first quarter of fiscal 2023, which ended June 17, 2023 results: revenue $24.1 billion, net income $417.2 million, EPS $0.72 per share.

Period: first quarter of fiscal 2023, which ended June 17, 2023
Revenue: $24.1 billion
Net income: $417.2 million
EPS: $0.72 per share
Result: reported results

Exact text from the filing

Net sales and other revenue was $24.1 billion during the 16 weeks ended June 17, 2023 ("first quarter of fiscal 2023") compared to $23.3 billion during the 16 weeks ended June 18, 2022 ("first quarter of fiscal 2022").

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

Albertsons Companies, Inc. filing history →

Source: SEC EDGAR

accession 0001646972-23-000051

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.